Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026
Source: SeekingAlpha
2026-03-06 01:16:40 ET
More on Profound Medical Corp.
- Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript
- Profound Medical announces pricing of up to $40 million financing
- Seeking Alpha’s Quant Rating on Profound Medical Corp.
- Historical earnings data for Profound Medical Corp.
- Financial information for Profound Medical Corp.
Read the full article on Seeking Alpha
For further details see:
Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026
Profound Medical Corp.
NASDAQ: PRN:CC
PRN:CC Trading
0.45% G/L:
$11.28 Last:
9,800 Volume:
$11.23 Open:
PRN:CC Latest News
March 09, 2026 08:30:00 am
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 05, 2026 04:05:00 pm
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026 04:30:00 pm
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th - Conference Call to Follow
